Global Metabotropic Glutamate Receptor 3 Market Growth (Status and Outlook) 2022-2028
- LP 4929002
- 88 Pages
- March 2022
- Pharmaceuticals
The United States Metabotropic Glutamate Receptor 3 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Metabotropic Glutamate Receptor 3 market, reaching US$ million by the year 2028. As for the Europe Metabotropic Glutamate Receptor 3 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Metabotropic Glutamate Receptor 3 players cover Addex Therapeutics Ltd, Aevi Genomic Medicine Inc, Denovo Biopharma LLC, and Domain Therapeutics SA, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Metabotropic Glutamate Receptor 3 market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
LY-3020371
VU-0092273
DT-010991
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Autism
Chronic Pain
Glioma
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Addex Therapeutics Ltd
Aevi Genomic Medicine Inc
Denovo Biopharma LLC
Domain Therapeutics SA
Eli Lilly and Company
Prexton Therapeutics SA
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Metabotropic Glutamate Receptor 3 Market Size 2017-2028
2.1.2 Metabotropic Glutamate Receptor 3 Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Metabotropic Glutamate Receptor 3 Segment by Type
2.2.1 LY-3020371
2.2.2 VU-0092273
2.2.3 DT-010991
2.2.4 Others
2.3 Metabotropic Glutamate Receptor 3 Market Size by Type
2.3.1 Metabotropic Glutamate Receptor 3 Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Metabotropic Glutamate Receptor 3 Market Size Market Share by Type (2017-2022)
2.4 Metabotropic Glutamate Receptor 3 Segment by Application
2.4.1 Autism
2.4.2 Chronic Pain
2.4.3 Glioma
2.4.4 Others
2.5 Metabotropic Glutamate Receptor 3 Market Size by Application
2.5.1 Metabotropic Glutamate Receptor 3 Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Metabotropic Glutamate Receptor 3 Market Size Market Share by Application (2017-2022)
3 Metabotropic Glutamate Receptor 3 Market Size by Player
3.1 Metabotropic Glutamate Receptor 3 Market Size Market Share by Players
3.1.1 Global Metabotropic Glutamate Receptor 3 Revenue by Players (2020-2022)
3.1.2 Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Players (2020-2022)
3.2 Global Metabotropic Glutamate Receptor 3 Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Metabotropic Glutamate Receptor 3 by Regions
4.1 Metabotropic Glutamate Receptor 3 Market Size by Regions (2017-2022)
4.2 Americas Metabotropic Glutamate Receptor 3 Market Size Growth (2017-2022)
4.3 APAC Metabotropic Glutamate Receptor 3 Market Size Growth (2017-2022)
4.4 Europe Metabotropic Glutamate Receptor 3 Market Size Growth (2017-2022)
4.5 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size Growth (2017-2022)
5 Americas
5.1 Americas Metabotropic Glutamate Receptor 3 Market Size by Country (2017-2022)
5.2 Americas Metabotropic Glutamate Receptor 3 Market Size by Type (2017-2022)
5.3 Americas Metabotropic Glutamate Receptor 3 Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Metabotropic Glutamate Receptor 3 Market Size by Region (2017-2022)
6.2 APAC Metabotropic Glutamate Receptor 3 Market Size by Type (2017-2022)
6.3 APAC Metabotropic Glutamate Receptor 3 Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Metabotropic Glutamate Receptor 3 by Country (2017-2022)
7.2 Europe Metabotropic Glutamate Receptor 3 Market Size by Type (2017-2022)
7.3 Europe Metabotropic Glutamate Receptor 3 Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Metabotropic Glutamate Receptor 3 by Region (2017-2022)
8.2 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Type (2017-2022)
8.3 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Metabotropic Glutamate Receptor 3 Market Forecast
10.1 Global Metabotropic Glutamate Receptor 3 Forecast by Regions (2023-2028)
10.1.1 Global Metabotropic Glutamate Receptor 3 Forecast by Regions (2023-2028)
10.1.2 Americas Metabotropic Glutamate Receptor 3 Forecast
10.1.3 APAC Metabotropic Glutamate Receptor 3 Forecast
10.1.4 Europe Metabotropic Glutamate Receptor 3 Forecast
10.1.5 Middle East & Africa Metabotropic Glutamate Receptor 3 Forecast
10.2 Americas Metabotropic Glutamate Receptor 3 Forecast by Country (2023-2028)
10.2.1 United States Metabotropic Glutamate Receptor 3 Market Forecast
10.2.2 Canada Metabotropic Glutamate Receptor 3 Market Forecast
10.2.3 Mexico Metabotropic Glutamate Receptor 3 Market Forecast
10.2.4 Brazil Metabotropic Glutamate Receptor 3 Market Forecast
10.3 APAC Metabotropic Glutamate Receptor 3 Forecast by Region (2023-2028)
10.3.1 China Metabotropic Glutamate Receptor 3 Market Forecast
10.3.2 Japan Metabotropic Glutamate Receptor 3 Market Forecast
10.3.3 Korea Metabotropic Glutamate Receptor 3 Market Forecast
10.3.4 Southeast Asia Metabotropic Glutamate Receptor 3 Market Forecast
10.3.5 India Metabotropic Glutamate Receptor 3 Market Forecast
10.3.6 Australia Metabotropic Glutamate Receptor 3 Market Forecast
10.4 Europe Metabotropic Glutamate Receptor 3 Forecast by Country (2023-2028)
10.4.1 Germany Metabotropic Glutamate Receptor 3 Market Forecast
10.4.2 France Metabotropic Glutamate Receptor 3 Market Forecast
10.4.3 UK Metabotropic Glutamate Receptor 3 Market Forecast
10.4.4 Italy Metabotropic Glutamate Receptor 3 Market Forecast
10.4.5 Russia Metabotropic Glutamate Receptor 3 Market Forecast
10.5 Middle East & Africa Metabotropic Glutamate Receptor 3 Forecast by Region (2023-2028)
10.5.1 Egypt Metabotropic Glutamate Receptor 3 Market Forecast
10.5.2 South Africa Metabotropic Glutamate Receptor 3 Market Forecast
10.5.3 Israel Metabotropic Glutamate Receptor 3 Market Forecast
10.5.4 Turkey Metabotropic Glutamate Receptor 3 Market Forecast
10.5.5 GCC Countries Metabotropic Glutamate Receptor 3 Market Forecast
10.6 Global Metabotropic Glutamate Receptor 3 Forecast by Type (2023-2028)
10.7 Global Metabotropic Glutamate Receptor 3 Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Addex Therapeutics Ltd
11.1.1 Addex Therapeutics Ltd Company Information
11.1.2 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Product Offered
11.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Addex Therapeutics Ltd Main Business Overview
11.1.5 Addex Therapeutics Ltd Latest Developments
11.2 Aevi Genomic Medicine Inc
11.2.1 Aevi Genomic Medicine Inc Company Information
11.2.2 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 3 Product Offered
11.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 3 Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Aevi Genomic Medicine Inc Main Business Overview
11.2.5 Aevi Genomic Medicine Inc Latest Developments
11.3 Denovo Biopharma LLC
11.3.1 Denovo Biopharma LLC Company Information
11.3.2 Denovo Biopharma LLC Metabotropic Glutamate Receptor 3 Product Offered
11.3.3 Denovo Biopharma LLC Metabotropic Glutamate Receptor 3 Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Denovo Biopharma LLC Main Business Overview
11.3.5 Denovo Biopharma LLC Latest Developments
11.4 Domain Therapeutics SA
11.4.1 Domain Therapeutics SA Company Information
11.4.2 Domain Therapeutics SA Metabotropic Glutamate Receptor 3 Product Offered
11.4.3 Domain Therapeutics SA Metabotropic Glutamate Receptor 3 Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Domain Therapeutics SA Main Business Overview
11.4.5 Domain Therapeutics SA Latest Developments
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Information
11.5.2 Eli Lilly and Company Metabotropic Glutamate Receptor 3 Product Offered
11.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 3 Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Eli Lilly and Company Main Business Overview
11.5.5 Eli Lilly and Company Latest Developments
11.6 Prexton Therapeutics SA
11.6.1 Prexton Therapeutics SA Company Information
11.6.2 Prexton Therapeutics SA Metabotropic Glutamate Receptor 3 Product Offered
11.6.3 Prexton Therapeutics SA Metabotropic Glutamate Receptor 3 Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Prexton Therapeutics SA Main Business Overview
11.6.5 Prexton Therapeutics SA Latest Developments
12 Research Findings and Conclusion
Table 1. Metabotropic Glutamate Receptor 3 Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of LY-3020371
Table 3. Major Players of VU-0092273
Table 4. Major Players of DT-010991
Table 5. Major Players of Others
Table 6. Metabotropic Glutamate Receptor 3 Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Metabotropic Glutamate Receptor 3 Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Metabotropic Glutamate Receptor 3 Market Size Market Share by Type (2017-2022)
Table 9. Metabotropic Glutamate Receptor 3 Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Metabotropic Glutamate Receptor 3 Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Metabotropic Glutamate Receptor 3 Market Size Market Share by Application (2017-2022)
Table 12. Global Metabotropic Glutamate Receptor 3 Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Player (2020-2022)
Table 14. Metabotropic Glutamate Receptor 3 Key Players Head office and Products Offered
Table 15. Metabotropic Glutamate Receptor 3 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Metabotropic Glutamate Receptor 3 Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Metabotropic Glutamate Receptor 3 Market Size Market Share by Regions (2017-2022)
Table 20. Americas Metabotropic Glutamate Receptor 3 Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Metabotropic Glutamate Receptor 3 Market Size Market Share by Country (2017-2022)
Table 22. Americas Metabotropic Glutamate Receptor 3 Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Metabotropic Glutamate Receptor 3 Market Size Market Share by Type (2017-2022)
Table 24. Americas Metabotropic Glutamate Receptor 3 Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Metabotropic Glutamate Receptor 3 Market Size Market Share by Application (2017-2022)
Table 26. APAC Metabotropic Glutamate Receptor 3 Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Metabotropic Glutamate Receptor 3 Market Size Market Share by Region (2017-2022)
Table 28. APAC Metabotropic Glutamate Receptor 3 Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Metabotropic Glutamate Receptor 3 Market Size Market Share by Type (2017-2022)
Table 30. APAC Metabotropic Glutamate Receptor 3 Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Metabotropic Glutamate Receptor 3 Market Size Market Share by Application (2017-2022)
Table 32. Europe Metabotropic Glutamate Receptor 3 Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Metabotropic Glutamate Receptor 3 Market Size Market Share by Country (2017-2022)
Table 34. Europe Metabotropic Glutamate Receptor 3 Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Metabotropic Glutamate Receptor 3 Market Size Market Share by Type (2017-2022)
Table 36. Europe Metabotropic Glutamate Receptor 3 Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Metabotropic Glutamate Receptor 3 Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Metabotropic Glutamate Receptor 3
Table 45. Key Market Challenges & Risks of Metabotropic Glutamate Receptor 3
Table 46. Key Industry Trends of Metabotropic Glutamate Receptor 3
Table 47. Global Metabotropic Glutamate Receptor 3 Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Metabotropic Glutamate Receptor 3 Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Metabotropic Glutamate Receptor 3 Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Metabotropic Glutamate Receptor 3 Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Metabotropic Glutamate Receptor 3 Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Metabotropic Glutamate Receptor 3 Market Size Market Share Forecast by Application (2023-2028)
Table 53. Addex Therapeutics Ltd Details, Company Type, Metabotropic Glutamate Receptor 3 Area Served and Its Competitors
Table 54. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Product Offered
Table 55. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Addex Therapeutics Ltd Main Business
Table 57. Addex Therapeutics Ltd Latest Developments
Table 58. Aevi Genomic Medicine Inc Details, Company Type, Metabotropic Glutamate Receptor 3 Area Served and Its Competitors
Table 59. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 3 Product Offered
Table 60. Aevi Genomic Medicine Inc Main Business
Table 61. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 3 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Aevi Genomic Medicine Inc Latest Developments
Table 63. Denovo Biopharma LLC Details, Company Type, Metabotropic Glutamate Receptor 3 Area Served and Its Competitors
Table 64. Denovo Biopharma LLC Metabotropic Glutamate Receptor 3 Product Offered
Table 65. Denovo Biopharma LLC Main Business
Table 66. Denovo Biopharma LLC Metabotropic Glutamate Receptor 3 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Denovo Biopharma LLC Latest Developments
Table 68. Domain Therapeutics SA Details, Company Type, Metabotropic Glutamate Receptor 3 Area Served and Its Competitors
Table 69. Domain Therapeutics SA Metabotropic Glutamate Receptor 3 Product Offered
Table 70. Domain Therapeutics SA Main Business
Table 71. Domain Therapeutics SA Metabotropic Glutamate Receptor 3 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Domain Therapeutics SA Latest Developments
Table 73. Eli Lilly and Company Details, Company Type, Metabotropic Glutamate Receptor 3 Area Served and Its Competitors
Table 74. Eli Lilly and Company Metabotropic Glutamate Receptor 3 Product Offered
Table 75. Eli Lilly and Company Main Business
Table 76. Eli Lilly and Company Metabotropic Glutamate Receptor 3 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Eli Lilly and Company Latest Developments
Table 78. Prexton Therapeutics SA Details, Company Type, Metabotropic Glutamate Receptor 3 Area Served and Its Competitors
Table 79. Prexton Therapeutics SA Metabotropic Glutamate Receptor 3 Product Offered
Table 80. Prexton Therapeutics SA Main Business
Table 81. Prexton Therapeutics SA Metabotropic Glutamate Receptor 3 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Prexton Therapeutics SA Latest Developments
List of Figures
Figure 1. Metabotropic Glutamate Receptor 3 Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Metabotropic Glutamate Receptor 3 Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Metabotropic Glutamate Receptor 3 Market Size Market Share by Type in 2021
Figure 7. Metabotropic Glutamate Receptor 3 in Autism
Figure 8. Global Metabotropic Glutamate Receptor 3 Market: Autism (2017-2022) & ($ Millions)
Figure 9. Metabotropic Glutamate Receptor 3 in Chronic Pain
Figure 10. Global Metabotropic Glutamate Receptor 3 Market: Chronic Pain (2017-2022) & ($ Millions)
Figure 11. Metabotropic Glutamate Receptor 3 in Glioma
Figure 12. Global Metabotropic Glutamate Receptor 3 Market: Glioma (2017-2022) & ($ Millions)
Figure 13. Metabotropic Glutamate Receptor 3 in Others
Figure 14. Global Metabotropic Glutamate Receptor 3 Market: Others (2017-2022) & ($ Millions)
Figure 15. Global Metabotropic Glutamate Receptor 3 Market Size Market Share by Application in 2021
Figure 16. Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Player in 2021
Figure 17. Global Metabotropic Glutamate Receptor 3 Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Metabotropic Glutamate Receptor 3 Market Size 2017-2022 ($ Millions)
Figure 19. APAC Metabotropic Glutamate Receptor 3 Market Size 2017-2022 ($ Millions)
Figure 20. Europe Metabotropic Glutamate Receptor 3 Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size 2017-2022 ($ Millions)
Figure 22. Americas Metabotropic Glutamate Receptor 3 Value Market Share by Country in 2021
Figure 23. Americas Metabotropic Glutamate Receptor 3 Consumption Market Share by Type in 2021
Figure 24. Americas Metabotropic Glutamate Receptor 3 Market Size Market Share by Application in 2021
Figure 25. United States Metabotropic Glutamate Receptor 3 Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Metabotropic Glutamate Receptor 3 Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Metabotropic Glutamate Receptor 3 Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Metabotropic Glutamate Receptor 3 Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Metabotropic Glutamate Receptor 3 Market Size Market Share by Region in 2021
Figure 30. APAC Metabotropic Glutamate Receptor 3 Market Size Market Share by Application in 2021
Figure 31. China Metabotropic Glutamate Receptor 3 Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Metabotropic Glutamate Receptor 3 Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Metabotropic Glutamate Receptor 3 Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Metabotropic Glutamate Receptor 3 Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Metabotropic Glutamate Receptor 3 Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Metabotropic Glutamate Receptor 3 Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Metabotropic Glutamate Receptor 3 Market Size Market Share by Country in 2021
Figure 38. Europe Metabotropic Glutamate Receptor 3 Market Size Market Share by Type in 2021
Figure 39. Europe Metabotropic Glutamate Receptor 3 Market Size Market Share by Application in 2021
Figure 40. Germany Metabotropic Glutamate Receptor 3 Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Metabotropic Glutamate Receptor 3 Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Metabotropic Glutamate Receptor 3 Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Metabotropic Glutamate Receptor 3 Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Metabotropic Glutamate Receptor 3 Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size Market Share by Application in 2021
Figure 48. Egypt Metabotropic Glutamate Receptor 3 Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Metabotropic Glutamate Receptor 3 Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Metabotropic Glutamate Receptor 3 Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Metabotropic Glutamate Receptor 3 Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Metabotropic Glutamate Receptor 3 Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 54. APAC Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 55. Europe Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 57. United States Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 58. Canada Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 61. China Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 62. Japan Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 63. Korea Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 65. India Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 66. Australia Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 67. Germany Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 68. France Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 69. UK Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 70. Italy Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 71. Russia Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 72. Spain Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 75. Israel Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Metabotropic Glutamate Receptor 3 Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
